Statin Safety: An Overview and Assessment of the Data—2005
作者： Harold Bays
DOI: 10.1016/J.AMJCARD.2005.12.006
关键词:
摘要: … various adverse effects are caused by statins. This review presents an assessment of statin safety based on an overview of the current statin safety data and their clinical implications. …
elsevier.com
sci-hub.se 参考文章(200)
Taha H Taher, Vladimir Dzavik, Ethel M Reteff, Glen J Pearson, Bonnie L Woloschuk, Gordon A Francis, Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events. American Journal of Cardiology. ,vol. 89, pp. 390- 394 ,(2002) , 10.1016/S0002-9149(01)02258-5
Leslie R. Wagstaff, Melinda W. Mitton, Beth McLendon Arvik, P. Murali Doraiswamy, Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. ,vol. 23, pp. 871- 880 ,(2003) , 10.1592/PHCO.23.7.871.32720
Monika Lechleitner, Fritz Hoppichler, Günther Konwalinka, JosefR. Patsch, Herbert Braunsteiner, Depressive symptoms in hypercholesterolaemic patients treated with pravastatin. The Lancet. ,vol. 340, pp. 910- 910 ,(1992) , 10.1016/0140-6736(92)93318-H
Dieter Felsenberg, Steven Boonen, The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clinical Therapeutics. ,vol. 27, pp. 1- 11 ,(2005) , 10.1016/J.CLINTHERA.2004.12.020
Donald M. Black, A general assessment of the safety of HMG CoA reductase inhibitors (statins). Current Atherosclerosis Reports. ,vol. 4, pp. 34- 41 ,(2002) , 10.1007/S11883-002-0060-0
N Cutler, J Sramek, A Veroff, G Block, L Stauffer, C Lines, Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia British Journal of Clinical Pharmacology. ,vol. 39, pp. 333- 336 ,(1995) , 10.1111/J.1365-2125.1995.TB04458.X
Memduh Ucar, Tom Mjorndal, Rune Dahlqvist, HMG-CoA reductase inhibitors and myotoxicity. Drug Safety. ,vol. 22, pp. 441- 457 ,(2000) , 10.2165/00002018-200022060-00003
James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott, Eldrin F. Lewis, Keith A. A. Fox, Harvey D. White, Jean-Lucien Rouleau, Terje R. Pedersen, Laura H. Gardner, Robin Mukherjee, Karen E. Ramsey, Joanne Palmisano, David W. Bilheimer, Marc A. Pfeffer, Robert M. Califf, Eugene Braunwald, for the A to Z Investigators, Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes JAMA. ,vol. 292, pp. 1307- 1316 ,(2004) , 10.1001/JAMA.292.11.1307
C. Christopher Smith, Lana I. Bernstein, Roger B. Davis, David M. Rind, Robert H. Shmerling, Screening for Statin-Related Toxicity Archives of Internal Medicine. ,vol. 163, pp. 688- 692 ,(2003) , 10.1001/ARCHINTE.163.6.688
Simon de Denus, Sarah A. Spinler, Kristin Miller, Andrew M. Peterson, Statins and Liver Toxicity: A Meta‐Analysis Pharmacotherapy. ,vol. 24, pp. 584- 591 ,(2004) , 10.1592/PHCO.24.6.584.34738